Punctal stenosis associated with dupilumab therapy for atopic dermatitis

Debora H. Lee*, Liza M. Cohen, Michael K. Yoon, Jeremiah P. Tao

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

In this case series, the authors report three patients with severe atopic dermatitis who presented with epiphora and conjunctivitis while undergoing dupilumab therapy. On clinical examination, all patients were found to have punctal stenosis, with one case having progressed to punctal obstruction. An assortment of strategies was elected, including discontinuation of dupilumab, treatment of conjunctivitis, and surgical intervention with probing, punctoplasty, and silicone intubation. This report spotlights punctal stenosis as an important new side effect of dupilumab and suggests that additional cases of dupilumab-associated lacrimal drainage impairment will continue to emerge.

Original languageEnglish (US)
Pages (from-to)737-740
Number of pages4
JournalJournal of Dermatological Treatment
Volume32
Issue number7
DOIs
StatePublished - 2021

Keywords

  • Dupilumab
  • atopic dermatitis
  • conjunctivitis
  • punctal obstruction
  • punctal stenosis

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Punctal stenosis associated with dupilumab therapy for atopic dermatitis'. Together they form a unique fingerprint.

Cite this